RecruitingNCT01499394

Caris Biorepository Research Protocol

The Caris Biorepository Research Protocol

Sponsor

Caris Science, Inc.

Enrollment

100,000 participants

Start Date

Nov 1, 2010

Study Type

OBSERVATIONAL

Conditions

Cancer Minimal Residual Disease Early Detection of Cancer

Summary

The Biorepository for Caris Life Sciences is designed for the purpose of making quality biospecimens and associated clinical data available for research studies related to advancing precision medicine and improving care for patients. The Caris Biorepository is a repository of prospectively collected biological specimens and associated clinical and demographic data gathered from multiple sources to be stored, used and shared for research. Caris Life Sciences will maintain the data and specimens and will control access to and use of the information and specimens by multiple individuals for multiple purposes which may evolve over time.

Eligibility

Min Age: 18 Years

Plain Language Summary

Simplified for easier understanding

This clinical trial is studying a new treatment for people with cancer, early detection of cancer, and other related conditions. The study is currently recruiting participants at 38 locations.

This summary was AI-generated to explain the trial in plain language. It is not medical advice. Always discuss eligibility with your doctor before enrolling in a clinical trial.

Interested in this trial?

Get notified about updates and connect with the research team.

Locations(38)

University of South Alabama

Mobile, Alabama, United States

Southwest Medical Imaging

Scottsdale, Arizona, United States

St. Bernards Medical Center

Jonesboro, Arkansas, United States

CARTI Cancer Center

Little Rock, Arkansas, United States

ObjectiveHealth - ARcare Center for Clinical Research

Little Rock, Arkansas, United States

Lee Memorial Health System

Fort Myers, Florida, United States

Cancer Care of North Florida

Lake City, Florida, United States

Advent Health

Orlando, Florida, United States

The University of South Florida

Tampa, Florida, United States

Cleveland Clinic Florida

Weston, Florida, United States

Phoebe Putney Memorial Hospital

Albany, Georgia, United States

Emory University

Atlanta, Georgia, United States

Augusta University Research Institute

Augusta, Georgia, United States

Cancer Center of Middle Georgia

Dublin, Georgia, United States

Hope and Healing Cancer Services

Hinsdale, Illinois, United States

CHRISTUS - St. Frances Cabrini Hospital

Alexandria, Louisiana, United States

Tulane University

New Orleans, Louisiana, United States

CHRISTUS - Highland Medical Center

Shreveport, Louisiana, United States

Mercy Medical Center

Baltimore, Maryland, United States

Sinai Hospital of Baltimore

Baltimore, Maryland, United States

Hattiesburg Clinic

Hattiesburg, Mississippi, United States

Jackson Oncology Associates

Jackson, Mississippi, United States

University of Mississippi Medical Center

Jackson, Mississippi, United States

ObjectiveHealth - Premier Health Research

Sparta, New Jersey, United States

CHRISTUS - St. Vincent Regional Cancer Center

Santa Fe, New Mexico, United States

St. Lawrence Health System

Potsdam, New York, United States

National Translational Research Group

Ridge, New York, United States

Altru Health System

Grand Forks, North Dakota, United States

NEO Urology Associates

Boardman, Ohio, United States

Great Lakes Medical Research

Cleveland, Ohio, United States

Bend Memorial Clinic

Bend, Oregon, United States

Clinical Biotechnology Research Institute at RSFH

Charleston, South Carolina, United States

Spartanburg Regional Health Services

Spartanburg, South Carolina, United States

West Cancer Center

Germantown, Tennessee, United States

ObjectiveHealth - Amarillo Premier Research

Amarillo, Texas, United States

CHRISTUS - St. Michael's Health

Texarkana, Texas, United States

CAMC Clinical Trials

Charleston, West Virginia, United States

Mercy Health

Janesville, Wisconsin, United States

View Full Details on ClinicalTrials.gov

For the most up-to-date information, visit the official listing.

Visit

NCT01499394

Related Trials

To Assess the Correlation of High-resolution Specimen PET-CT Imaging, Using the XEOS AURA 10 PET-CT, With the Histopathology Results and Long-term Outcome of Patients Undergoing Resective Cancer Surgery.

NCT069702754 locations

Selpercatinib Pre-RAI in Patients With RET Fusion Thyroid Cancer (RAISE)

NCT064580365 locations

Transdiagnostic Intervention to Reduce Internalized Health-Related Stigma

NCT055615951 location

Patient Descriptors Of Cancer-Related Fatigue: A Mixed Methods Pilot Study Of Cancer Survivors

NCT066343813 locations

The Florida ASCENT Study

NCT070422431 location